- Home
- KLTOW vs VLY Comparison
KLTOW vs VLY Comparison
Compare KLTOW & VLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- VLY
- Stock Information
- Founded
- KLTOW N/A
- VLY 1927
- Country
- KLTOW United States
- VLY United States
- Employees
- KLTOW 3
- VLY N/A
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- VLY Major Banks
- Sector
- KLTOW Health Care
- VLY Finance
- Exchange
- KLTOW Nasdaq
- VLY Nasdaq
- Market Cap
- KLTOW N/A
- VLY 5.2B
- IPO Year
- KLTOW 2022
- VLY N/A
- Fundamental
- Price
- KLTOW $0.10
- VLY $10.73
- Analyst Decision
- KLTOW
- VLY Buy
- Analyst Count
- KLTOW 0
- VLY 12
- Target Price
- KLTOW N/A
- VLY $11.75
- AVG Volume (30 Days)
- KLTOW N/A
- VLY 7.5M
- Earning Date
- KLTOW N/A
- VLY 10-23-2025
- Dividend Yield
- KLTOW N/A
- VLY 4.13%
- EPS Growth
- KLTOW N/A
- VLY 9.10
- EPS
- KLTOW N/A
- VLY 0.78
- Revenue
- KLTOW N/A
- VLY $1,603,358,000.00
- Revenue This Year
- KLTOW N/A
- VLY $33.98
- Revenue Next Year
- KLTOW N/A
- VLY $8.90
- P/E Ratio
- KLTOW N/A
- VLY $13.66
- Revenue Growth
- KLTOW N/A
- VLY N/A
- 52 Week Low
- KLTOW N/A
- VLY $7.48
- 52 Week High
- KLTOW N/A
- VLY $11.10
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- VLY 67.05
- Support Level
- KLTOW N/A
- VLY $10.46
- Resistance Level
- KLTOW N/A
- VLY $10.94
- Average True Range (ATR)
- KLTOW 0.00
- VLY 0.23
- MACD
- KLTOW 0.00
- VLY -0.02
- Stochastic Oscillator
- KLTOW 0.00
- VLY 72.63
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About VLY Valley National Bancorp
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.